Welcome to the Institute of Clinical Research

About Us

The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.

For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community. For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.

It is the membership that makes the Institute.

How does it all work ?

The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.

The Board is made up of members who give their time freely to guide the future direction of the ICR.

The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.

Our Mission

The ICR exists to support our members through all stages of their careers. We do this, in part, by:

Defining and refining standards for our profession
Providing a forum for discussion of key issues impacting clinical research
Promoting good relations with other healthcare related groups
Providing opportunities for learning and development to enhance professional competence
Enhancing public confidence and understanding of clinical research

Current News

Novavax begins COVID-19, flu combination vaccine trial

By ICR Secretariat / 16/09/2021 10:32 AM

Novavax has launched a Phase I/II study evaluating a combination vaccine for the prevention of both COVID-19 and seasonal influenza, the US biotech co…

Covid: Vaccine protection still strong - Oxford jab creator

By ICR Secretariat / 16/09/2021 10:30 AM

The vaccines are still providing strong protection, a year on from the initial two doses, says the scientist who developed the Oxford-AZ vaccine.

AstraZeneca's COVID-19 shot joins the list of vaccines flagged for rare Guillain-Barre syndrome

By ICR Secretariat / 16/09/2021 10:29 AM

Two months after the FDA flagged Johnson & Johnson’s COVID-19 vaccine for the rare nerve disorder Guillain-Barre syndrome (GBS) Europe’s drug regu…

At FDA meeting, gene therapy experts wrestle with field's blindspots

By ICR Secretariat / 09/09/2021 03:00 PM

A group of gene therapy experts called for better research tools and more careful monitoring of side effects to treatment, but stopped short in a high…

NICE recommends Novartis’ Cosentyx for children with severe psoriasis

By ICR Secretariat / 09/09/2021 02:58 PM

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ interleukin-17A (IL-17A) inhibitor Cosentyx (secukinumab) for t…

Pfizer, Merck launch large new trials of oral COVID-19 drugs

By ICR Secretariat / 09/09/2021 02:55 PM

Pfizer and Merck & Co. each launched pivotal clinical studies of new experimental oral COVID-19 drugs, building on previous work to provide outpa…

Study finds protection against COVID-19 ‘waning’ in fully vaccinated people

By ICR Secretariat / 06/09/2021 11:44 AM

New real-world study data has found that protection against COVID-19 is ‘waning’ in individuals who have received two vaccine doses.

ESC 2021: Lexicon aims to make its heart failure case with sotagliflozin, a dual SGLT1 and SGLT2 inhibitor

By ICR Secretariat / 26/08/2021 04:06 PM

While much of the attention at the European Society of Cardiology (ESC) is expected to center on forthcoming heart failure data for Eli Lilly and Boeh…

With new Fate data, same promise, questions surround 'natural killer' cell therapy

By ICR Secretariat / 26/08/2021 04:05 PM

Fate Therapeutics reported new results for two early-stage studies testing two different types of experimental lymphoma treatments that utilize natur…

EC nod for Astellas, FibroGen’s roxadustat for chronic kidney disease

By ICR Secretariat / 26/08/2021 04:04 PM

The European Commission (EC) has approved Evrenzo (roxadustat) for the treatment of adult patients with symptomatic anaemia associated with chronic ki…

FDA OK's third dose of Moderna's COVID-19 vaccine for immunocompromised

By ICR Secretariat / 19/08/2021 03:43 PM

The US Food and Drug Administration (FDA) has approved an update to the emergency use authorisation for Moderna’s COVID-19 vaccine – mRNA-1273 – to in…

Covid: Carrie Johnson urges pregnant women to get vaccinated

By ICR Secretariat / 19/08/2021 03:42 PM

Carrie Johnson has said she is "feeling great" after having her second Covid jab, as she encouraged other pregnant women to get the vaccine.

The…

Biden embraces Medicare drug price negotiation as Democrats seek to widen health coverage

By ICR Secretariat / 19/08/2021 03:41 PM

President Joe Biden embraced congressional Democrats' broad drug pricing agenda, announcing Thursday his support for legislation that would allow Medi…

Covid map: Coronavirus cases, deaths, vaccinations by country

By ICR Secretariat / 12/08/2021 02:56 PM

Covid-19 is continuing to spread around the world, with more than 200 million confirmed cases and more than 4.2 million deaths across nearly 200 count…

From vaccine halo to liability? Reputation tracker says COVID-19 shot makers now dinged for safety, supply issues

By ICR Secretariat / 12/08/2021 02:54 PM

COVID-19 vaccine makers' time in the sun is over, according to one reputation tracker. The reputation boost ignited by the rush to find solutions duri…

Useful Downloads

View more downloads